Casper F. Bruens

DSM Pharmaceuticals, Inc. provides contract manufacturing services to the pharmaceutical and biotechnology industries. It offers manufacturing services in the areas of sterile, and orals & topical, including dose form manufacturing, scheduled drugs, clinical manufacturing, fill finish manufacturing, aseptic filling, terminal sterilization, cold storage, ampoules, vials, and lyophilization. The company is headquartered in Greenville, NC.

Novum Medical, Inc. operates as a medical device company. It engages in the development of advanced orthobiomaterials utilizing a proprietary process capable of producing structures that are both strong and porous. The company was founded by Paul K. Nichols, Jr. and is headquartered in Woburn, MA.

IsoTis NV manufactures, markets and sells a range of bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Bilthoven, the Netherlands

Part of Abbott Laboratories, Abbott Healthcare Products BV is a Dutch company that manufactures and distributes pharmaceuticals. The company is based in Weesp, Netherlands.

Part of DSM-Firmenich AG, DSM Biologics Holding, Inc. is a Canadian company that manufactures biological and pharmaceutical products. The private company is based in Montréal, Canada. The company was founded by Jos van Weperen. DSM Biologics Holding was acquired by DSM Pharmaceuticals, Inc., a subsidiary of DSM-Firmenich AG from Province of Québec on July 13, 2005.

Upfront Chromatography A/S develops a customized protein separation process. The firm offers industrial-scale customized separation solutions to isolate and purify soluble proteins from industrial process streams. Its core protein purification technology, rhobust, is applicable to industrial feed stocks. The company was founded by Allan Otto Fog Lihme in 1992 and is headquartered in Copenhagen, Denmark.

Brabantse Ontwikkelings Maatschappij Holding BV (BOM) is an industrial and economic development agency headquarterd in Tilburg in the southern Netherlands. Established in 1983, BOM is funded and financed by the Dutch State and the Province of Noord-Brabant. The firm offers a range of services designed to create, develop, maintain and improve the industrial structure of the region through four core activities: venture capital, foreign investment, new business and industrial parks. In particular BOM manages the Technostartersfonds, also known as the TechnoStars funds, which are regional venture capital investment vehicles based in Eindhoven. The investors are primarily institutions and high-net worth private individuals.

Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada.

Triodos Investment Management BV (Triodos Investment Management) is a private equity/venture capital firm subsidiary of Triodos Bank NV founded in 1980. The firm is headquartered is headquartered in Zeist, Netherlands.

DSM Special Products BV specializes in providing toluene oxidation technology. The company uses technologies for the production of benzoic acid (Purox B) and sodium benzoate (Purox S). Its products are used in a range of applications, such as food, carbonated soft drinks, animal feed, plasticisers, resins, personal care, flavours, and fragrances. The firm was founded in 2004 and is headquartered in Rotterdam, the Netherlands.

Regentis Biomaterials Ltd. engages in the research and development of proprietary hydrogels for local repair of damaged cartilage and bone. Its product is GelrinC. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom.

Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom.

Isobionics BV operates as a holding company, which produces flavor and fragrance ingredients. The firm manufactures and supplies natural chemical substances such as Valencene, Nootkatone, and Beta-Elemene. The company was founded by Toine Janssen in 2008 and is headquartered in Geleen, the Netherlands.

Part of Van Lanschot Kempen NV, Van Lanschot Bankiers (Curaçao) NV is a banking company based in Willemstad, Netherlands. Founded in 1962, the Dutch company provides banking services.

OrthAlign Corp. engages in the provision of precision alignment technology and products. It offers orthopedic services. The company was founded by Pieter Wolters and Curt Stone in 2008 and is headquartered in Aliso Viejo, CA.

IsoTis Orthobiologics Inc. develops, manufactures and markets proprietary products for the treatment of musculoskeletal diseases and disorders. Its products include bone graft substitutes that promote the regeneration of bone and are used to repair natural, trauma-related and surgically-created defects common in orthopedic procedures, including spinal fusions. The company was founded in 2003 and is headquartered in Irvine, CA.

Cottonwood Technology Group LLC (Cottonwood Technology Fund) is a venture capital firm founded in 2009 by Ebetuel Pallares and David Blivin. The firm is headquarters in Santa Fe, New Mexico.

United Telecom NV develops software technologies for mobile operators. It provides fixed and mobile telephony and VDSL products. The company was founded in 1990 and is headquartered in Rotselaar, Belgium.

Prometheus is an independent network of four southern-European think tanks that specialize in economic, business, and geopolitical research. The private company is based in Antwerp, Belgium, and have subsidiaries in Belgium. Prometheus recently published a report on the music production and reproduction ecosystem. The Belgian company was founded in 2006 by Clyde Davis.

FABPulous BV develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability. It offers ultra rapid plasma preparation platform that can make a defined dilution of plasma from a small volume of whole blood in seconds and integrated lateral flow IVD platform. The company’s tests provide diagnosis and benefit to the patient, as well as the healthcare sector, the insurance industry, governments and society in general. FABPulous was founded in 2008 and is headquartered in Maastricht, the Netherlands.

DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands.

Essential Medical, Inc. designs, develops, and markets medical and surgical devices. It specializes in vascular closure devices that seals the opening created from cardiac catheterizations in leg arteries. The company was founded by Gary S. Roubin and Greg A. Walters in 2010 and is headquartered in Wayne, PA.

SABIC Ventures BV is a venture capital firm founded in 2011. The firm headquartered in Netherlands.

QBIC Venture Partners BVBA (QBIC Venture Partners) is a venture capital firm founded in 2012 by Marc Zabeau. The firm is headquartered in Belgium.

Caloritum NV offers innovative technology to industrial customers. The firm provides transform wasted heat into useful process heat and reduces the total energy bill by saving fossil fuels and CO2 emissions. The company was founded by Wouter Ducheyne and Christian Heeren in 2012 and is headquartered in Antwerp, Belgium.

Frontier Nutrition, Inc. develops and manufactures fortified packaged food. Its recipes are localized for traditional diets, taste, and nutrition. The company was founded by Eddie Bearnot and Tanveer Ali on August 18, 2016 and is headquartered in DE.

DegenRx BV is a Dutch biotech company that is focused on developing AAV-mediated gene therapy for the treatment of CNS diseases such as Alzheimer's and Parkinson's disease. The company is based in Tilburg, Netherlands. The company aims to address the lack of drugs available to stop or slow down the progression of Alzheimer's disease, which affects about two-thirds of the 50 million people reported to suffer from dementia worldwide. One of the approaches most advanced in clinical studies is immunotherapy against amyloid beta, which DegenRx is working on. Inez de Greef-van der Sand has been the CEO of the company since 2020.

Leading Edge Equipment Technologies, Inc. engages in the manufacture and sale of semiconductor devices. The company was founded by Alison Greenlee in 2016 and is headquartered in Wilminton, MA.

Synvina CV engages in the manufacture of plastics. It offer furandicarboxylic acid and polyethylene furanoate products. The company is headquartered in Amsterdam, the Netherlands.

Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands.

Neuroplast BV is a Dutch stem cell technology company that focuses on developing autologous cell products for the treatment of primarily inflammation-driven neurological disorders. Neuroplast is located in Brightlands Chemelot Campus in the Netherlands. The company's transformative treatment, Neuro-cellsò, is currently being tested for traumatic spinal cord injury (TSCI) and aims to reduce the irreversible impact of TSCI during the crucial first phase. The company was founded in August 2014 by physician De Munter and neurologist Erik Wolters, and current investors include Invest, Brightlands Venture Partners, and Liof NV. Johannes de Munter has been the CEO of the company since 2016.

VOID Technologies Ltd. is a British company that manufactures polyethylene film. The company is based in Beaconsfield, UK. The company was founded in 2014.

Alloksys Life Sciences BV provides therapies services. It offers Phase 3 clinical trials leading to registration of RESCAP (RESCuing Alkaline Phosphatase) for the prevention and treatment of ischemic injury and inflammation mediated complications in cardiothoracic surgery (APPIRED III). The company was founded by Ruud Brands in 2005 and is headquartered in Wageningen, the Netherlands.